|
Market Research Report
Chinese Markets for Bladder Cancer Treatment
|
Chinese Markets for Bladder Cancer Treatment published by Asia Market Information & Development in September, 2009. This report consists of 200 Pages and the price starts from US $ 4000.
Abstract
China' s demand for Bladder Cancer Treatment Drugs has grown at a fast pace in
the past decade. In the next five years, both production and demand will
continue to grow. This new study examines China' s economic trends, investment
environment, industry development, supply and demand, industry capacity,
industry structure, marketing channels and major industry participants.
Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013
and 2018 are presented. Major producers in China are profiled
Table of Contents
I. INTRODUCTION
- Report Scope and Methodology
- Executive Summary
II. BUSINESS ENVIRONMENT
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
- Bladder Cancer Treatment Drugs Industry Structure
- Market Size
- Market Growth Drivers
- Bladder Cancer Treatment Drugs Sales Volume
- Major Producer Facility Locations
- Major Producers' Sales Volume and Market Share
- Labor Cost
- Potential Entrants
- Major Distributors
- Major Foreign Investment
- Technology Development
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
- Bladder Cancer Overview
- Bladder Cancer Treatment Drugs Market Overview
- Bladder Cancer Treatment Drugs Market Overview by Classification
- Intraluminal Perfusion Agents
- Unilateral Chemotherapy Drug
- First-line Chemotherapy Drug
- Other Drugs
- Bladder Cancer Treatment Drugs Import and Export by Classification
- Bladder Cancer Treatment Drugs Import
- Bladder Cancer Treatment Drugs Export
- Market Overview by Drug' s Active Principle
- Market Overview by Producers
- Pricing Trend
V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK
- Bladder Cancer Treatment Drugs Markets Outlook Overview
- Government Regulation
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
VI. MARKETING STRATEGIES
- China Market Entry Overview
- China' s Distribution System
- Bladder Cancer Treatment Drugs Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China' s Market Entry
- Export to China
- Indirect export
- Direct Export
- License and Contract Manufacture
- Assembling in China
- Contract Manufacturing
- Trade Permit
- Investment
- Equity Joint Venture
- Contractual Joint Venture
- Wholly Foreign-Owned Enterprise
VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY
- Profiles of Bladder Cancer Treatment Drugs Producers
LIST OF TABLES
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
- Key Economic Indicators
- Industrial Output
- Population and Labor Force Trends
- Foreign Investment and Loans
- Foreign Trade
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
- Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share in 2008
- Bladder Cancer Treatment Drugs Sales Volume
- Major Producer Facility Location
- Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their
Market Share in 2008
- Major Foreign Investment in China
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
- Bladder Cancer Treatment Drugs Import by Country in 2008
- Bladder Cancer Treatment Drugs Export by Country in 2008
- Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
- Bladder Cancer Treatment Drugs Import by Drugs Classification
- Bladder Cancer Treatment Drugs Export by Drugs Classification
- Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market
Share in 2008
- Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share
in 2008
- Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market
Share in 2008
V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
- Bladder Cancer Treatment Drugs Sales Volume
II. BUSINESS ENVIRONMENT
- China' s GDP and Growth Rate
- Industrial Output by Ownership
- China' s Imports and Exports
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
- Bladder Cancer Treatment Drugs Sales Volume
- Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008
- Top 14 Bladder Cancer Treatment Drugs Market Share in 2008
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
- Bladder Cancer Treatment Drugs Sales Volume
- Bladder Cancer Treatment Drugs Import
- Bladder Cancer Treatment Drugs Import by Country in 2008
- Bladder Cancer Treatment Drugs Export
- Bladder Cancer Treatment Drugs Export by Country in 2008
- Bladder Cancer Treatment Drugs Sales Volume by Classification in 2008
- Intraluminal Perfusion Agents Sales Volume and Market Share
- Unilateral Chemotherapy Drug Sales Volume and Market Share
- First-Line Chemotherapy Drug Sales Volume and Market Share
- Immunomodulator Sales Volume and Market Share
- Other Drugs Sales Volume and Market Share
- Bladder Cancer Treatment Drugs Import by Classification in 2008
- Unilateral Chemotherapy Drug Import and Market Share
- First-Line Chemotherapy Drug Import and Market Share
- Intraluminal Perfusion Agents Import and Market Share
- Immunomodulator Import and Market Share
- Other Drugs Import and Market Share
- Bladder Cancer Treatment Drugs Export by Drugs Classification in 2008
- Unilateral Chemotherapy Drug Export and Market Share
- First-Line Chemotherapy Drug Export and Market Share
- Intraluminal Perfusion Agents Export and Market Share
- Immunomodulator Export and Market Share
VI. MARKETING STRATEGIES
|
